PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
Reinhard ReussDepartment of Neurology, BKH Bayreuth, Bayreuth, GermanyAbstract: Current standard immunomodulatory therapy with interferons (IFNs) for relapsing–remitting multiple sclerosis (MS) exhibits proven, but limited, efficacy and increased side effects due to the need of frequent ap...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2f25c22240904349a17b83337b13b965 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|